SEC Company Response from Universe Pharmaceuticals INC (UPC) (CIK 0001809616) (UPC) — Mar 17, 2021
Universe Pharmaceuticals INC (UPC) (CIK 0001809616)
Date: March 17, 2021 · CIK: 0001809616 · Accession: 0001213900-21-016140
AI Filing Summary & Sentiment
File numbers found in text: 333-248067
Show Raw Text
CORRESP
1
filename1.htm
March 17, 2021
Via Edgar
Mr. Alan Campbell
Division of Corporation Finance
Office of Life Sciences
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, D.C., 20549
Re:
Universe Pharmaceuticals INC
Registration Statement on Form F-1/A (File No. 333-248067)
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
In accordance with Rule
461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Securities Act”), Univest
Securities, LLC, as the underwriter, hereby requests acceleration of the effective date of the above-referenced Registration Statement
so that it will become effective at 4:00 p.m., Eastern Time, on March 22, 2021, or as soon thereafter as practicable.
Pursuant to Rule 460 under
the Securities Act, please be advised that there will be distributed to each underwriter, who is reasonably anticipated to be invited
to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to
be reasonable to secure adequate distribution of the preliminary prospectus.
We are aware of our obligations
under and confirm that they are complying with the provisions of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended,
including the delivery requirement contained in such Rule.
Very truly yours,
Univest Securities,
LLC
By: /s/ Edric Guo
Name: Edric Guo
Title: Chief Operating Officer